Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys (a component of X-ray units that holds X-ray film cassettes). This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.
IPO Year:
Exchange: NASDAQ
Website: vareximaging.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/23/2024 | $21.00 | Buy | B. Riley Securities |
| 10/12/2022 | $24.00 | Hold | Jefferies |
4 - Varex Imaging Corp (0001681622) (Issuer)
4 - Varex Imaging Corp (0001681622) (Issuer)
Varex Imaging Corporation (NASDAQ:VREX) today announced its unaudited financial results for the first quarter of fiscal year 2025. 1QFY25 Summary Revenues of $200 million GAAP gross margin 34% | Non-GAAP gross margin* 35% GAAP operating margin 6% | Non-GAAP operating margin* 7% GAAP net loss $0.01 per diluted share | Non-GAAP net earnings* $0.07 per diluted share Cash flow from operations was $10 million Sunny Sanyal, Chief Executive Officer, stated, "Demand in the first quarter was solid, with both Medical and Industrial revenue up year-over-year. Favorable sales mix and productivity gains across both segments resulted in higher than expected profitability and earnings
Varex Imaging Corporation (NASDAQ:VREX) today announced that it will report unaudited financial results for the first quarter of fiscal year 2025 following the close of regular trading on Thursday, February 6, 2025. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also access this conference call at 877-524-8416 from anywhere in the U.S. or 412-902-1028 from non-U.S. locations. The webcast of this call will be archived on the company's website and a replay of the call will be available from February 6th thr
Varex Imaging Corporation (NASDAQ:VREX) today announced its unaudited financial results for the fourth quarter and fiscal year 2024. Q4 FY24 Summary Revenues of $206 million GAAP gross margin 33% | Non-GAAP gross margin* 33% GAAP operating expense $56 million | Non-GAAP operating expense* $53 million GAAP operating margin 5% | Non-GAAP operating margin* 7% GAAP net earnings $(1.22) per diluted share | Non-GAAP net earnings* $0.19 per diluted share Cash flow from operations $26 million FY24 Summary Revenues of $811 million GAAP gross margin 32% | Non-GAAP gross margin* 32% GAAP operating expense $225 million | Non-GAAP operating expense* $210 million GAAP o
Varex Imaging Corporation (NASDAQ:VREX) today announced that it will report unaudited financial results for the fourth quarter and full fiscal year 2024 following the close of regular trading on Tuesday, November 19, 2024. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also access this conference call at 877-524-8416 from anywhere in the U.S. or 412-902-1028 from non-U.S. locations. The webcast of this call will be archived on the company's website and a replay of the call will be available from November 1
Varex Imaging Corporation (NASDAQ:VREX) today announced its unaudited financial results for the third quarter of fiscal year 2024. 3QFY24 Summary Revenues $209 million GAAP gross margin 32% | Non-GAAP gross margin* 32% GAAP operating margin 4% | Non-GAAP operating margin* 7% GAAP net earnings $0.03 per diluted share | Non-GAAP net earnings* $0.14 per diluted share Cash flow from operations was $8 million Sunny Sanyal, Chief Executive Officer, stated, "Revenue in the third quarter of fiscal 2024 came in as expected, driven primarily by continued strength in our cargo inspection business, which drove a 6% year-over-year increase in our Industrial segment." Varex's revenu
Varex Imaging Corporation (NASDAQ:VREX) today announced that it will report unaudited financial results for the third quarter of fiscal year 2024 following the close of regular trading on Thursday, August 1, 2024. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also access this conference call at 877-524-8416 from anywhere in the U.S. or 412-902-1028 from non-U.S. locations. The webcast of this call will be archived on the company's website and a replay of the call will be available from August 1st through
Varex Imaging Corporation (NASDAQ:VREX) today announced its unaudited financial results for the second quarter of fiscal year 2024. 2QFY24 Summary Revenues $206 million GAAP gross margin 32% | Non-GAAP gross margin* 33% GAAP operating margin 4% | Non-GAAP operating margin* 6% GAAP net earnings $0.03 per diluted share | Non-GAAP net earnings* $0.16 per diluted share Cash flow from operations was $3 million "Revenue of $206 million in the second quarter was in line with guidance, but down year-over-year primarily due to lower sales to our customers in China," said Sunny Sanyal, Chief Executive Officer of Varex. "Sales in the first half of fiscal 2024 were as expected, but
Varex Imaging Corporation (NASDAQ:VREX) today announced that it will report unaudited financial results for the second quarter of fiscal year 2024 following the close of regular trading on Thursday, May 2, 2024. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also access this conference call at 877-524-8416 from anywhere in the U.S. or 412-902-1028 from non-U.S. locations. The webcast of this call will be archived on the company's website and a replay of the call will be available from May 2nd through May
Varex Imaging Corporation (NASDAQ:VREX) today announced its unaudited financial results for the first quarter of fiscal year 2024. 1QFY24 Summary Revenues $190 million GAAP gross margin 30% | Non-GAAP gross margin* 31% GAAP operating margin 2% | Non-GAAP operating margin* 5% GAAP net loss $0.01 per diluted share | Non-GAAP net earnings* $0.06 per diluted share Cash flow from operations was $10 million "Revenue of $190 million in the first quarter of fiscal 2024, was at the mid-point of our guidance, however unfavorable mix in both the Medical and Industrial segments impacted profitability." said Sunny Sanyal, Chief Executive Officer of Varex. Varex's revenue of $190 mi
Varex Imaging Corporation (NASDAQ:VREX) today announced that it will report unaudited financial results for the first quarter of fiscal year 2024 following the close of regular trading on Tuesday, February 6, 2024. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also access this conference call at 877-524-8416 from anywhere in the U.S. or 412-902-1028 from non-U.S. locations. The webcast of this call will be archived on the company's website and a replay of the call will be available from February 6th thro
NEW YORK, Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 23, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from
B. Riley Securities initiated coverage of Varex Imaging with a rating of Buy and set a new price target of $21.00
Jefferies initiated coverage of Varex Imaging with a rating of Hold and set a new price target of $24.00
Oppenheimer upgraded Varex Imaging from Market Perform to Outperform and set a new price target of $35.50
Oppenheimer initiated coverage of Varex Imaging with a rating of Neutral and set a new price target of $35.50
Oppenheimer upgraded Varex Imaging from Perform to Outperform and set a new price target of $41.00
SC 13G/A - Varex Imaging Corp (0001681622) (Subject)
SC 13G/A - Varex Imaging Corp (0001681622) (Subject)
SC 13G/A - Varex Imaging Corp (0001681622) (Subject)
SC 13G - Varex Imaging Corp (0001681622) (Subject)
SC 13G - Varex Imaging Corp (0001681622) (Subject)
SC 13G/A - Varex Imaging Corp (0001681622) (Subject)
SC 13G/A - Varex Imaging Corp (0001681622) (Subject)
SC 13G - Varex Imaging Corp (0001681622) (Subject)
SC 13G/A - Varex Imaging Corp (0001681622) (Subject)
SC 13G/A - Varex Imaging Corp (0001681622) (Subject)
Varex Imaging Corporation (NASDAQ:VREX) today announced its unaudited financial results for the first quarter of fiscal year 2025. 1QFY25 Summary Revenues of $200 million GAAP gross margin 34% | Non-GAAP gross margin* 35% GAAP operating margin 6% | Non-GAAP operating margin* 7% GAAP net loss $0.01 per diluted share | Non-GAAP net earnings* $0.07 per diluted share Cash flow from operations was $10 million Sunny Sanyal, Chief Executive Officer, stated, "Demand in the first quarter was solid, with both Medical and Industrial revenue up year-over-year. Favorable sales mix and productivity gains across both segments resulted in higher than expected profitability and earnings
Varex Imaging Corporation (NASDAQ:VREX) today announced that it has received orders for non-intrusive cargo inspection systems valued at approximately $14 million USD. The orders are for the recently launched high energy inspection systems, VXP-6 Portal and VXM-6 Mobile systems for cargo and vehicle inspection, which are designed to assist in securing ports and borders. Varex Imaging CEO, Sunny Sanyal, stated, "We are excited to see the interest and adoption in the newly launched product line of full screening systems." Sanyal added, "Our reputation in high energy linear accelerators enables us to engage with end-users and strengthen our portfolio of offerings to our customers to help sec
Varex Imaging Corporation (NASDAQ:VREX) announced today that management is scheduled to participate in the following upcoming investor conferences. BTIG at Snowbird: The 12th Annual MedTech, Digital Health, LS&D Tools Conference in Salt Lake City, UT – Wednesday, February 12, 2025 (1x1 meetings only) B. Riley Securities Precision Oncology & Radiopharma Conference – Friday, February 28, 2025 in New York, NY (1x1 meetings only) About Varex Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that are key components of X-ray imaging systems. With a 70
Varex Imaging Corporation (NASDAQ:VREX) today announced that it will report unaudited financial results for the first quarter of fiscal year 2025 following the close of regular trading on Thursday, February 6, 2025. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also access this conference call at 877-524-8416 from anywhere in the U.S. or 412-902-1028 from non-U.S. locations. The webcast of this call will be archived on the company's website and a replay of the call will be available from February 6th thr
Varex Imaging Corporation (NASDAQ:VREX) announced today that management is scheduled to present at the CJS Securities 25th Annual New Ideas for the New Year Virtual Conference. Management will be presenting on Tuesday, January 14, 2025 at 2:20pm ET. The webcast can be accessed here or on Varex's website at www.vareximaging.com/news. About Varex Varex Imaging Corporation is a leading innovator, designer, and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that are key components of X-ray imaging systems. With a 75 year history of successful innovation, Varex's products are used in medical imaging as well as in
Varex Imaging Corporation (NASDAQ:VREX) today announced it has closed its private offering (the "Offering") of $125 million aggregate principal amount of 7.875% senior secured notes due 2027 (the "notes") at an offering price of 101.5% of the principal amount thereof, plus accrued interest from and including October 15, 2024. "We are pleased to have successfully closed the offering of additional senior secured notes," said Sam Maheshwari, Chief Financial Officer of Varex Imaging Corporation. "The additional funds allow us to address the partial repayment of our convertible notes coming due in June 2025, while preserving availability under our revolving credit facility," added Maheshwari.
Varex Imaging Corporation (NASDAQ:VREX) today announced it has priced a private offering (the "Offering") of $125 million aggregate principal amount of 7.875% senior secured notes due October 15, 2027 (the "notes") at an offering price of 101.5% of the principal amount thereof, plus accrued and unpaid interest from October 15, 2024. The notes offered hereby will be issued as "Additional Notes" under the Indenture and will constitute a further issuance of our 7.875% senior secured notes due 2027, which were initially issued in an aggregate principal amount of $300 million on September 30, 2020, of which $243 million aggregate principal amount is outstanding. Varex intends to use the net proc
Varex Imaging Corporation (NASDAQ:VREX) today announced it has commenced a private offering (the "Offering"), subject to market and other conditions, of $125 million aggregate principal amount of its 7.875% senior secured notes due October 15, 2027 (the "notes"). The notes offered hereby will be issued as "Additional Notes" and will constitute a further issuance of our 7.875% senior secured notes due 2027, which were initially issued in an aggregate principal amount of $300 million on September 30, 2020, of which $243 million aggregate principal amount is outstanding. Varex intends to use the net proceeds from the sale of the notes to fund the partial repayment of the Company's outstanding
Varex Imaging Corporation (NASDAQ:VREX) today announced that its 2025 Annual Meeting of Stockholders will be held in virtual format only at 4:30 pm Mountain Time on Thursday, February 13, 2025. Stockholders will not be able to attend the 2025 annual meeting in person. Varex stockholders of record at the close of business on December 16, 2024 will be entitled to receive notice of the Annual Meeting and to vote upon matters considered at the meeting. Varex will make available to all stockholders of record important information about the Annual Meeting and the matters to be considered. Information on how to attend the virtual meeting will be included in the meeting materials to be sent to
Varex Imaging Corporation (NASDAQ:VREX) is proud to introduce the LUMEN HD and LUMEN HD Pro digital radiography detectors, designed to meet the evolving standards of healthcare imaging. As the demands of medical imaging continue to shift, these detectors are built to offer reliable, fast, and user-friendly performance in today's cost-conscious environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241201481997/en/LUMEN HD Pro: Built for the new demands in imaging. (Graphic: Business Wire) Key Features and Benefits: Reliable. The LUMEN family of detectors are designed for uninterrupted flow of the highest image quality, m
SCHEDULE 13G/A - Varex Imaging Corp (0001681622) (Subject)
10-Q - Varex Imaging Corp (0001681622) (Filer)
8-K - Varex Imaging Corp (0001681622) (Filer)
SCHEDULE 13G/A - Varex Imaging Corp (0001681622) (Subject)
SCHEDULE 13G/A - Varex Imaging Corp (0001681622) (Subject)
DEFA14A - Varex Imaging Corp (0001681622) (Filer)
DEFA14A - Varex Imaging Corp (0001681622) (Filer)
DEF 14A - Varex Imaging Corp (0001681622) (Filer)
8-K - Varex Imaging Corp (0001681622) (Filer)
PRE 14A - Varex Imaging Corp (0001681622) (Filer)
4 - Varex Imaging Corp (0001681622) (Issuer)
4 - Varex Imaging Corp (0001681622) (Issuer)
4 - Varex Imaging Corp (0001681622) (Issuer)
4 - Varex Imaging Corp (0001681622) (Issuer)
4 - Varex Imaging Corp (0001681622) (Issuer)
4 - Varex Imaging Corp (0001681622) (Issuer)
4 - Varex Imaging Corp (0001681622) (Issuer)
4 - Varex Imaging Corp (0001681622) (Issuer)
4 - Varex Imaging Corp (0001681622) (Issuer)
4 - Varex Imaging Corp (0001681622) (Issuer)